Emerging Biomarkers in AFP-Low HCC: Evaluating the Role of Fibroblast Growth Factor 19 after Locoregional Treatment

Authors

  • Amany Mohammed Ibrahim, Fady Maher Wadea, Sameh Saber Bayoumi , Marwa Mohammed Esawy , Heba Sayed Ahmed Abdel Hamid Elsayed

Keywords:

AFP, Fibroblast Growth Factor 19, HCC

Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide and remains a leadingcause of cancer-related mortality. Locoregional therapies, including transarterial chemoembolization (TACE),radiofrequency ablation (RFA), microwave ablation, and radioembolization, form the backbone of treatment for patientswho are not candidates for surgical resection or transplantation.

Downloads

Download data is not yet available.

References

Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301-1314.

Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.

Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the AASLD. Hepatology. 2018;68(2):723-750.

Downloads

Published

2024-03-20

How to Cite

Amany Mohammed Ibrahim, Fady Maher Wadea, Sameh Saber Bayoumi , Marwa Mohammed Esawy , Heba Sayed Ahmed Abdel Hamid Elsayed. (2024). Emerging Biomarkers in AFP-Low HCC: Evaluating the Role of Fibroblast Growth Factor 19 after Locoregional Treatment. Pegem Journal of Education and Instruction, 14(3), 666–674. Retrieved from https://www.pegegog.net/index.php/pegegog/article/view/4231

Issue

Vol. 14 No. 3 (2024): PEGEGOG

Section

Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

NonCommercial — You may not use the material for commercial purposes.

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.